INS and obesity disorder: Additionally, GLP-1 inhibits appetite, promotes satiety, delays gastric emptying, improves insulin sensitivity, stimulates beta-cell regeneration, and prevents beta cell apoptosis, making it a promising target for diabetes and obesity treatment [58].